Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Pattarozzi

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Pituitary|November 19, 2010
In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5Federico Gatto, Federica Barbieri, Lara Castelletti, et al.
Haematologica|April 14, 2011
An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the diseasePaolo Giannoni, Silvia Scaglione, Rodolfo Quarto, et al.
Annals of the New York Academy of Sciences|March 27, 2007
CXC receptor and chemokine expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferationFederica Barbieri, Adriana Bajetto, Carola Porcile, et al.
Annals of the New York Academy of Sciences|January 22, 2005
The phosphotyrosine phosphatase eta mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2Alessandro Massa, Federica Barbieri, Cinzia Aiello, et al.
The Journal of Biological Chemistry|May 5, 2004
The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferationAlessandro Massa, Federica Barbieri, Cinzia Aiello, et al.
Annals of the New York Academy of Sciences|March 27, 2007
SDF-1 controls pituitary cell proliferation through the activation of ERK1/2 and the Ca2+-dependent, cytosolic tyrosine kinase Pyk2Alessandro Massa, Silvia Casagrande, Adriana Bajetto, et al.
Molecular Pharmacology|November 1, 2005
Chemokine stromal cell-derived factor 1alpha induces proliferation and growth hormone release in GH4C1 rat pituitary adenoma cell line through multiple intracellular signalsTullio Florio, Silvia Casagrande, Fabrizio Diana, et al.
Cell Cycle (Georgetown, Tex.)|November 15, 2015
The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastomaBarbara Banelli, Elisa Carra, Federica Barbieri, et al.
Current Cancer Drug Targets|January 22, 2010
Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to inhibit pleural mesothelioma cell proliferationRoberto E Favoni, Alessandra Pattarozzi, Michele Lo Casto, et al.
Molecular Cancer Therapeutics|August 24, 2018
Mutual Influence of ROS, pH, and CLIC1 Membrane Protein in the Regulation of G<sub>1</sub>-S Phase Progression in Human Glioblastoma Stem CellsMarta Peretti, Federica Maddalena Raciti, Valentina Carlini, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Pituitary|November 19, 2010
In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5Federico Gatto, Federica Barbieri, Lara Castelletti, et al.
Haematologica|April 14, 2011
An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the diseasePaolo Giannoni, Silvia Scaglione, Rodolfo Quarto, et al.
Annals of the New York Academy of Sciences|March 27, 2007
CXC receptor and chemokine expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferationFederica Barbieri, Adriana Bajetto, Carola Porcile, et al.
Annals of the New York Academy of Sciences|January 22, 2005
The phosphotyrosine phosphatase eta mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2Alessandro Massa, Federica Barbieri, Cinzia Aiello, et al.
The Journal of Biological Chemistry|May 5, 2004
The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferationAlessandro Massa, Federica Barbieri, Cinzia Aiello, et al.
Annals of the New York Academy of Sciences|March 27, 2007
SDF-1 controls pituitary cell proliferation through the activation of ERK1/2 and the Ca2+-dependent, cytosolic tyrosine kinase Pyk2Alessandro Massa, Silvia Casagrande, Adriana Bajetto, et al.
Molecular Pharmacology|November 1, 2005
Chemokine stromal cell-derived factor 1alpha induces proliferation and growth hormone release in GH4C1 rat pituitary adenoma cell line through multiple intracellular signalsTullio Florio, Silvia Casagrande, Fabrizio Diana, et al.
Cell Cycle (Georgetown, Tex.)|November 15, 2015
The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastomaBarbara Banelli, Elisa Carra, Federica Barbieri, et al.
Current Cancer Drug Targets|January 22, 2010
Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to inhibit pleural mesothelioma cell proliferationRoberto E Favoni, Alessandra Pattarozzi, Michele Lo Casto, et al.
Molecular Cancer Therapeutics|August 24, 2018
Mutual Influence of ROS, pH, and CLIC1 Membrane Protein in the Regulation of G<sub>1</sub>-S Phase Progression in Human Glioblastoma Stem CellsMarta Peretti, Federica Maddalena Raciti, Valentina Carlini, et al.
Pageof 5